Sign In
Buy PFE
$27.05
+0.290 (+1.08%)
At Close: Aug 10, 2026
Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?
01:40pm, Monday, 10'th Aug 2026
Impairment charges crippled Pfizer's recent earnings. The company's free cash flow, however, remains fairly strong.
Pfizer Rises Almost 7% Post Q2 Results: How to Play the Stock
10:21am, Monday, 10'th Aug 2026
Pfizer's Q2 beat and raised 2026 revenue outlook signal progress, but declining COVID sales and patent losses challenge its growth path.
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
03:28pm, Friday, 07'th Aug 2026
Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the stock, despite the potential headwinds ahead.
Monster insider trading alert for Pfizer stock
10:40am, Friday, 07'th Aug 2026
As Pfizer Inc. (NYSE: PFE) stock gained over 5% this week fueled by its strong second quarter 2026 earnings report, Finbold has observed its increased insider trading.
After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?
12:00pm, Thursday, 06'th Aug 2026
Pfizer (NYSE:PFE | PFE Price Prediction) and Merck (NYSE:MRK) refreshed the dividend debate with their latest quarterly reports.
Pfizer: Q2 Strength Overshadows Obesity Setbacks
09:59am, Thursday, 06'th Aug 2026
Pfizer shares edged higher after Q2 earnings, shrugging off criticism over the discontinuation of two obesity drug candidates, MET-224o and PF-07976016. PFE highlighted Metsera's rapid progress and pl
Boomers Should Buy These High-Yield Dividend August Bargains Hand-Over-Fist
08:46am, Thursday, 06'th Aug 2026
Second-quarter earnings season shook loose some rare discounts on five high-yield dividend stocks that Wall Street analysts still rate as Buys, and income-focused investors may not get another shot at
Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts
11:02am, Wednesday, 05'th Aug 2026
PFE raises its 2026 revenue outlook as non-COVID growth, deeper cost cuts and pipeline catalysts offset weaker COVID demand.
Pfizer Q2 Earnings Call Highlights
08:04am, Wednesday, 05'th Aug 2026
Pfizer NYSE: PFE reported second-quarter 2026 revenue of $15 billion and adjusted diluted earnings per share of $0.77, with management saying both measures exceeded its internal expectations. Revenue
Pfizer Inc. (PFE) Q2 2026 Earnings Call Transcript
04:20pm, Tuesday, 04'th Aug 2026
Pfizer Inc. (PFE) Q2 2026 Earnings Call Transcript
PFE Q2 Earnings Top, 2026 Sales View Tweaked, COVID Forecast Cut
12:46pm, Tuesday, 04'th Aug 2026
Pfizer beats Q2 earnings and revenue estimates, raises the low end of its 2026 sales outlook, but lowers expectations for COVID product revenues.
Compared to Estimates, Pfizer (PFE) Q2 Earnings: A Look at Key Metrics
10:31am, Tuesday, 04'th Aug 2026
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to W
Pfizer raises revenue outlook after quarterly earnings top estimates
10:28am, Tuesday, 04'th Aug 2026
Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired produ
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings
09:41am, Tuesday, 04'th Aug 2026
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 700 points on Tuesday.
Pfizer (PFE) Q2 Earnings and Revenues Top Estimates
09:06am, Tuesday, 04'th Aug 2026
Pfizer (PFE) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.78 per share a year ago.
